“NVIDIA is Buying 8 Smaller A.I. Stocks for the Future! (Should You Follow?)”
GENB is a high-risk investment due to significant cash burn and extreme valuation multiples, despite Nvidia's recent stake; ranked low by the speaker.
Uh, this stock really, I feel hints at where Jensen Huang might be seeing the next frontier of AI in drug discovery with Generate Biomedicine, ticker symbol GENB, GenB, which Nvidia just recently picked up around $14 million worth.
Yet, that's still only about uh, 0.02% of their portfolio. That's how big they are. But, you know, compared to the billions that they spend on that Nvidia spends on semiconductors, uh, $14 million here might sound like pocket change for Nvidia, but investing directly into a clinical stage biotech is actually a pretty big signal to track.